|Mr. Josef H. von Rickenbach||Founder, Chairman & CEO||1.72M||7.3M||62|
|Dr. Mark A. Goldberg M.D.||Pres & COO||957.58k||990.73k||57|
|Mr. Douglas A. Batt||Sr. VP, Gen. Counsel & Sec.||N/A||N/A||57|
|Mr. Gadi Saarony||Sr. VP of Clinical Research Services||N/A||N/A||49|
|Mr. Simon Harford||Sr. VP & CFO||N/A||N/A||N/A|
PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions, such as spirometry, electronic clinical outcomes, and wearables. The company has a collaboration agreement with Sanofi. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham, Massachusetts.
PAREXEL International Corporation’s ISS Governance QualityScore as of August 1, 2017 is 7. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 10; Compensation: 1.